Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsh PC, Scardino PT, Lange PH, Subong EN, Parson RE, Gasior GH, Loveland KG, Southwick PC. Catalona WJ, et al. Among authors: gasior gh. JAMA. 1998 May 20;279(19):1542-7. doi: 10.1001/jama.279.19.1542. JAMA. 1998. PMID: 9605898 Clinical Trial.
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.
Southwick PC, Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, Walsh PC, Scardino PT, Lange PH, Gasior GH, Parson RE, Loveland KG. Southwick PC, et al. Among authors: gasior gh. J Urol. 1999 Oct;162(4):1346-51. J Urol. 1999. PMID: 10492194 Clinical Trial.
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial.
Catalona WJ, Partin AW, Slawin KM, Naughton CK, Brawer MK, Flanigan RC, Richie JP, Patel A, Walsh PC, Scardino PT, Lange PH, deKernion JB, Southwick PC, Loveland KG, Parson RE, Gasior GH. Catalona WJ, et al. Among authors: gasior gh. Urology. 2000 Mar;55(3):372-6. doi: 10.1016/s0090-4295(99)00547-6. Urology. 2000. PMID: 10699613 Clinical Trial.
Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen.
Chan DW, Kelley CA, Ratliff TL, D'Agostino D, Ritchey J, Lamb DJ, Beck J, Lott N, Wener MH, Daum P, Henkin RE, Kaske DN, Golightly DW, McBride J, Layco G, Ota MK, Tanasijevic MJ, Grudzien C, Woodrum DL, Bray KR, Southwick PC, Gasior GH, Loveland KG. Chan DW, et al. Among authors: gasior gh. Clin Chem. 1999 Oct;45(10):1863-5. Clin Chem. 1999. PMID: 10508137 Clinical Trial. No abstract available.
Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index.
Skikne BS, Punnonen K, Caldron PH, Bennett MT, Rehu M, Gasior GH, Chamberlin JS, Sullivan LA, Bray KR, Southwick PC. Skikne BS, et al. Among authors: gasior gh. Am J Hematol. 2011 Nov;86(11):923-7. doi: 10.1002/ajh.22108. Epub 2011 Aug 2. Am J Hematol. 2011. PMID: 21812017 Free article. Clinical Trial.
Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study.
Gratama JW, Boeckh M, Nakamura R, Cornelissen JJ, Brooimans RA, Zaia JA, Forman SJ, Gaal K, Bray KR, Gasior GH, Boyce CS, Sullivan LA, Southwick PC. Gratama JW, et al. Among authors: gasior gh. Blood. 2010 Sep 9;116(10):1655-62. doi: 10.1182/blood-2010-03-273508. Epub 2010 May 27. Blood. 2010. PMID: 20508161 Free article.